This site uses cookies to store information on your computer. Some are essential to make our site work; others help us improve the user experience. By using the site, you consent to the placement of these cookies. Read our privacy statement to learn more.

Medtronic is focused on less invasive therapies for the
millions of women that suffer from Pelvic disorders due to the cancer, pain, and benign disease.

Minimally Invasive Hysterectomy (MIH) offers clinical and economic benefits:
*Reduced rates of complications as
infections, blood loss, incisional hernias, adhesions and postoperative pain.
*Reduced hospital stay:
MIS patients are back to their routine faster than those who had abdominal surgery.
*Readmissions with lower costs on patient care. *

Explore our Global Value Dossier for MIH:

*For full claims and supporting references please refer to the Global Value Dossier